抗菌药物管理项目对急性白血病患者抗生素使用及耐药负担的影响:一项采用中断时间序列分析的11年纵向队列研究
该回顾性干预性纵向队列研究纳入7754例患者、3296次血流感染发作和454419个治疗日,评估多维抗菌药物管理项目对急性白血病患者抗生素使用和耐药菌血流感染的影响。项目与总体抗生素使用立即下降70.03 DOT/1000患者日及每季度下降11.65 DOT/1000患者日的趋势相关,耐药菌血流感染增长趋势被遏制并转为下降,肠杆菌目尤其显著,但铜绿假单胞菌血流感染增加。
要点
- 抗菌药物管理项目使总体抗生素使用立即减少70.03 DOT/1000患者日(P=0.036)。
- 干预后耐药菌血流感染由上升转为下降趋势(斜率变化-0.06 BSI/1000患者日/季度,P=0.002)。
- 肠杆菌目耐药菌血流感染下降更显著,但铜绿假单胞菌血流感染增加。
核心结论
- 多维抗菌药物管理项目有效降低了急性白血病患者总体抗生素使用的即刻水平和长期趋势。
- 耐药菌引起的血流感染发生率显著下降,尤其是肠杆菌目。
- 铜绿假单胞菌血流感染增加。
研究设计与样本
- 回顾性、干预性、纵向队列研究,跨度11年。
- 共纳入7754例患者,获得3296次血流感染发作和454419个治疗日(DOT)。
- 采用中断时间序列的分段回归模型评估干预后抗生素消耗和耐药菌血流感染的趋势。
主要发现
- 抗菌药物管理项目与总体抗生素使用立即减少70.03 DOT/1000患者日相关(P=0.036),并呈每季度下降11.65 DOT/1000患者日的趋势(P<0.001)。
- 干预前耐药菌血流感染发生率上升,干预后该上升趋势被显著遏制并转为下降(斜率变化:-0.06 BSI/1000患者日/季度,P=0.002)。
- 肠杆菌目中,环丙沙星耐药分离株和产ESBL分离株的血流感染斜率变化分别为-0.06 BSI/1000患者日和-0.08 BSI/1000患者日/季度(均P<0.05)。
- 铜绿假单胞菌血流感染增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR), driven by inappropriate and overuse of antibiotics, poses a significant threat, especially to patients with acute leukaemia. OBJECTIVES: To evaluate the impact of antimicrobial stewardship programmes (ASPs) on antibiotic use and analyse temporal changes in bloodstream infections (BSI) caused by AMR organisms. METHODS: We performed a retrospective, interventional, longitudinal cohort study spanning an 11-year period. ASPs included optimizing antibiotic use, enhancing tracking and reporting systems and delineating leadership and accountability. A segmented regression model of interrupted time series was used to evaluate the trend of antibiotic consumption and BSI with AMR organisms after the interventions. RESULTS: A total of 3296 BSI episodes with 454 419 days of therapy (DOT) from 7754 patients were obtained. ASPs were significantly associated with an immediate reduction [-70.03 DOT/1000 patient-days (PD), P = 0.036] and a decreasing trend (-11.65 DOT/1000 PD per quarter, P < 0.001) in overall antibiotic use. The increasing incidence of BSI with AMR before ASP intervention was notably curbed and revealed a decreasing trend (slope change: -0.06 BSI/1000 PD per quarter, P = 0.002). The decreasing trend was more significant for Enterobacterales: ciprofloxacin-resistant and ESBL-producing isolates showed a slope change of -0.06 BSI/1000 PD and -0.08 BSI/1000 PD per quarter, respectively (all P < 0.05). However, Pseudomonas aeruginosa BSI increased. CONCLUSIONS: Multidimensional ASPs effectively reduced both the immediate and trends in overall antibiotic usage even in patients with acute leukaemia. Additionally, there was a notable decrease in the incidence of BSI caused by AMR organisms, particularly among Enterobacterales.
引用
- Lee R, Nho D, Cho SY, et al. Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis. J Antimicrob Chemother. 2024. PMID: 38863389. doi:10.1093/jac/dkae199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。